Visualizing Intracellular Sialylation with Click Chemistry and Expansion Microscopy
February 7th, 2025
Here, we propose a simple protocol combining metabolic oligosaccharide engineering, click chemistry, and expansion microscopy that allows bioimaging of intracellular sialylated N-glycoproteins with improved resolution using routine microscopy equipment.
Overview
This study introduces a protocol for visualizing intracellular sialylated glycoconjugates using a combination of metabolic labeling, click chemistry, and expansion microscopy. The method significantly enhances spatial resolution without the need for specialized super-resolution microscopy equipment, making it accessible for various laboratories.
Key Study Components
Research Area
- Cell biology
- Microscopy
- Glycobiology
Background
- Intracellular visualization of glycoconjugates is crucial for understanding their roles in cellular processes.
- Previous techniques required expensive equipment and extensive optimization.
- The expansion microscopy approach physically enlarges samples for improved resolution.
Methods Used
- Combination of metabolic oligosaccharide engineering, click chemistry, and expansion microscopy.
- Cell cultures treated with N-azidoacetylmannosamine for sialylation.
- Standard microscopy techniques supplemented by expansion methods.
Main Results
- Enhanced visualization of subcellular structures.
- Significant increase in resolution post-expansion.
- Clear distinction of vesicles and organelles previously obscured.
Conclusions
- This study provides a cost-effective and efficient method for intracellular bioimaging.
- The protocol broadens access to high-resolution imaging techniques in biological research.
Frequently Asked Questions
Executive Industry Relevance
High-resolution visualization of intracellular sialylation is critical for understanding glycan-mediated mechanisms in disease-relevant systems. This protocol enables accessible, quantitative mapping of sialylated glycans in subcellular compartments, supporting mechanistic de-risking and target validation in early discovery. By eliminating the need for super-resolution equipment, it broadens translational research capabilities across enterprise R&D portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of glycosylation pathways and sialylation dynamics in cellular models.
- Supports functional target validation by mapping biosynthesis, trafficking, and recycling of sialoconjugates.
- Facilitates mechanistic de-risking by providing spatially resolved glycan localization data.
- Improves predictive confidence for glycan-related target selection and triage.
Screening & Assay Development
- Prepares validated intracellular labeling systems for downstream screening workflows.
- Delivers reproducible, quantitative fluorescence outputs for assay standardization.
- Enables scalable imaging using routine microscopy platforms, supporting platform reuse.
- Provides robust readouts for compound evaluation targeting glycosylation pathways.
Translational & Preclinical Research
- Aligns with disease-relevant models by enabling visualization of glycan alterations in pathological contexts.
- Supports continuity from discovery through preclinical validation by tracking intracellular glycan dynamics.
- Informs risk-adjusted advancement decisions based on spatial glycan distribution data.
- Enhances predictive de-risking for glycan-targeted therapeutic strategies.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum by enabling high-resolution, quantitative imaging of intracellular glycans using standard laboratory infrastructure.
- Discovery Biology: Supports hypothesis testing and pathway clarification for glycosylation-related targets.
- Screening: Provides assay-ready, reproducible labeling and imaging for compound screening.
- Analytics: Generates quantitative fluorescence measurements for comparative analysis of cellular conditions.
- Translational Research: Connects glycan imaging to disease models and biomarker alignment where supported.
- Enterprise Reuse: Offers a broadly transferable imaging capability for diverse R&D teams.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in glycan biology.
- Operational Value: Standardizes high-resolution imaging without specialized equipment, improving scalability.
- Strategic Value: Enables better go/no-go decisions and capital efficiency by clarifying glycan-related mechanisms.
- Portfolio Impact: Supports risk-adjusted prioritization of glycosylation-targeted programs.
Implementation Considerations
- Requires expertise in metabolic labeling, click chemistry, and fluorescence microscopy.
- Needs access to standard fluorescence microscopes and image analysis software.
- Demands cross-team standardization of labeling and imaging protocols for reproducibility.
- Adaptable to various cell types and model systems with protocol optimization.
- Expansion factor and imaging parameters must be validated for each application.
Biopharma FAQs
Chapters in this video
0:00
Introduction
1:04
Metabolic Oligosaccharide Engineering to Tag Sialylated Glycans, CuAAC Labeling of Sialylated Glycans, Immunofluorescence Staining of Cells for Expansion Imaging
3:43
Expansion Microscopy Protocol for Imaging Intracellular Sialylated N-Glycoproteins
5:11
Imaging of Organic Fluorophores Tagged Sialylated N-Glycoproteins
7:26
Representative Results
